We found a matchYour institution may have access to this item. Find your institution then sign in to continue.Title3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.AuthorsMcKinley ET; Smith RA; Zhao P; Fu A; Saleh SA; Uddin MI; Washington MK; Coffey RJ; Manning HCPublicationJournal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Vol 54, Issue 3, p424ISSN1535-5667Publication typearticleDOI10.2967/jnumed.112.108456